CCSD code M5520 – Artificial urinary sphincter implantation

Key takeaways

M5520 covers implantation, removal, or removal with reimplantation of an artificial urinary sphincter at the bladder neck, all under one code.

Cystoscopy is bundled into M5520, and CCSD lists the cystoscopy codes M4510 and M4514 as unacceptable combinations with it.

Most avoidable claim queries come from a missing pre-authorisation, a separately billed cystoscopy, or an operative note that skips an AUS component.

The AUS device is reimbursed outside the M5520 surgical fee, so confirm each insurer’s implant route before surgery.

Pabau’s claims management software sends CCSD-coded claims to insurers through Healthcode and tracks each one until it is paid.

CCSD Code M5520: definition and clinical scope

CCSD Code M5520 is the procedure code for implantation of artificial urinary sphincter at bladder neck and/or removal (including cystoscopy). It sits in Chapter 12 of the CCSD schedule, urinary system and male reproductive organs, under sub-chapter 12.3.0 Bladder. UK private medical insurers use the schedule to identify the procedure a consultant bills for.

Three parts of the descriptor decide how you code. The site is the bladder neck, not a more distal urethral position. The phrase “and/or removal” puts primary implantation, standalone removal, and removal with immediate reimplantation under the same code.

The parenthetical “(including cystoscopy)” is a bundling statement. Any cystoscopy in the same operative episode is part of M5520 and cannot attract a separate procedure fee.

The procedure: how artificial urinary sphincter implantation works

The AMS 800, made by Boston Scientific, is the most widely used artificial urinary sphincter (AUS) in UK urology. It has three hydraulically connected components, all implanted during the M5520 procedure.

• Urethral cuff: encircles the urethra at the bladder neck and closes it at rest to keep the patient continent.
• Pressure-regulating balloon: sits in the prevesical space and holds the cuff at a preset pressure, typically 61-70 cmH₂O for post-prostatectomy cases.
• Control pump: sits in the scrotum. The patient squeezes it to deflate the cuff for a short time and pass urine.

Implantation follows a perineal or penoscrotal approach. The surgeon positions the cuff, connects the tubing, fills the system, and confirms function before closing. Intraoperative cystoscopy is commonly performed to rule out urethral or bladder injury and is included within M5520.

Removal follows a similar exposure, with the surgeon disconnecting and explanting all three components. A cystoscopy after explantation to look for erosion or perforation is again included within M5520.

Clinical indications supported by M5520

Post-prostatectomy incontinence is the main indication for AUS implantation in UK urology, usually after radical prostatectomy for prostate cancer. The International Consultation on Incontinence names the AUS as the preferred option for men with moderate to severe post-prostatectomy stress incontinence.

Accepted clinical indications for M5520 include the following.

• Stress urinary incontinence after radical prostatectomy, the most common scenario. A urodynamic study should show intrinsic sphincter deficiency.
• Sphincter deficiency after pelvic radiotherapy for prostate or bladder cancer. Revision rates run higher in this group, so document the radiotherapy history.
• Neurogenic sphincter insufficiency from spinal cord injury or myelomeningocele, where a sling would not be enough.
• Failed earlier incontinence surgery, with the previous procedure documented and a clinical reason for choosing an AUS over a repeat sling.

The ICD-10 codes most often paired with M5520 are N39.3 (stress incontinence) and N32.8 (other specified disorders of bladder). UK insurers work from WHO ICD-10, so use the four-character codes rather than US ICD-10-CM extensions.

A pre-operative urodynamic study confirming sphincter deficiency is the standard supporting evidence. Make sure the operative note references those findings and that the same ICD-10 code appears on the invoice. The study itself is billed separately under M4780, usually in an earlier episode.

What M5520 includes and what it excludes

The inclusion and exclusion rules for M5520 decide what else can appear on the same invoice, and errors here cause many M5520 claim queries. The diagram sorts each item into what the code covers, what CCSD bars from the same claim, and what is billed on its own route.

The device cost needs the most care. The AMS 800 carries a high list price, and insurers differ in how they reimburse it. Some cover the implant through a separate approved implant tariff, while others negotiate directly with the hospital.

Confirm the arrangement with each insurer before surgery and record it in the pre-authorisation request. Never put the device cost on the M5520 surgical fee line without explicit insurer agreement.

Coding M5520 for removal vs implantation

The “and/or removal” clause puts three clinical scenarios under one code. The scenario changes what the operative note must record, not which code you use.

Insurers sometimes ask whether removal-only episodes should attract a lower fee. CCSD does not set fees, so the code itself says nothing about the rate for removal. If an insurer pays removal-only episodes differently, settle it at pre-authorisation rather than by choosing another code.

Adjacent CCSD codes and how to choose between them

M5520 sits beside several M-series codes for the bladder outlet, and picking the wrong neighbour is a common error. CCSD lists the three codes below as unacceptable combinations with M5520, so none of them belongs on the same claim. Every neighbouring urology code is in our full CCSD code library.

Consultants billing Bupa can check current values in our Bupa CCSD code guide.

Revision surgery: coding sphincter erosion, infection, and mechanical failure

Cuff erosion, device infection, and mechanical failure are the three main complications that send an AUS patient back to theatre. Each one needs its own detail in the operative note.

Where the revision removes or replaces the sphincter at the bladder neck, the M5520 descriptor covers it. How a revision is paid depends on each insurer’s policy, not on a CCSD rule. The note must state the indication clearly enough for the insurer’s clinical reviewer to confirm medical necessity.

A revision inside an insurer’s post-operative period may still need its own pre-authorisation, even when the policy covers revision. Do not assume the original authorisation extends to it. Contact the insurer before the revision theatre date.

Documentation requirements for a successful CCSD Code M5520 claim

A complete M5520 claim file usually holds five elements. A missing one gives the insurer’s clinical team grounds to return the claim or ask for more information, which can delay settlement by weeks.

1. Pre-authorisation reference number: the major UK private insurers expect pre-authorisation for AUS implantation before surgery. The reference must appear on the invoice, or the claim is declined on administrative grounds.
2. Operative note describing all three AUS components: the note names the urethral cuff, pressure-regulating balloon, and control pump. It records the device model, serial or lot numbers, cuff size, and balloon pressure range.
3. ICD-10 diagnosis code: put N39.3 or the applicable code on the invoice, matched to the indication in the clinic letter and urodynamics report.
4. Pre-operative urodynamics report: rarely sent with the first claim, but most insurers ask for it on review. Keep it filed in the patient record, ready to attach.
5. Consultant GMC registration: insurers need it to recognise the consultant. It is usually on file already, but check it each year for new recognition agreements.

Pre-authorisation: what UK private insurers require for M5520

Pre-authorisation requirements for AUS implantation vary between insurers. The table shows the evidence each major insurer typically asks for. Policies change, so confirm current requirements with each insurer’s provider helpline before you submit.

Pre-authorisation confirms that the procedure is covered under the patient’s policy. It does not guarantee that the device cost will be reimbursed too. Have that conversation with the patient before the consent appointment, so the hospital invoice holds no surprises.

Common claim denial reasons for M5520 and how to avoid them

Check for these five errors before you submit an M5520 claim.

• Separately billed cystoscopy: adding a separate cystoscopy code to an M5520 invoice gets the line rejected as an unacceptable combination. The cystoscopy is inside M5520 by definition.
• Missing pre-authorisation: a claim without a valid pre-authorisation reference is declined on administrative grounds, not clinical ones. Confirm the reference before the operating list closes.
• Incomplete operative note: clinical reviewers look for all three AUS components by name, with device model and lot numbers. A note reading only “AUS implanted” cannot show that the procedure matched the authorised code.
• Incorrect or absent ICD-10 code: the invoice code must match the indication in the pre-authorisation request and the operative note. Insurers flag any mismatch between them.
• Device cost inside the surgical fee line: putting the AMS 800 cost into the M5520 fee without separate implant approval leads to a partial rejection. Bill the device through each insurer’s approved route.

How Pabau supports CCSD billing for urology procedures

Most urology practices still build CCSD invoices by hand, then key each claim into a separate insurer portal. Pabau, the practice software we build, opens each claim pre-filled from the invoice, so the M5520 line and its ICD-10 code are entered once.

Pabau’s Healthcode-connected claims management then sends private medical insurance claims through Healthcode to Bupa, AXA Health, Vitality and other insurers. Insurer pre-authorisations are stored against the patient as a case, and the reference carries through to the claim.

The claims dashboard tracks each claim from pending to paid, with days overdue shown on every row. When an insurer pays, you record the payment once and match it to every invoice it covers, so the surgical fee never sits unreconciled.

Send CCSD claims to insurers without rekeying

Pabau pre-fills each claim from the invoice, carries the pre-authorisation reference through, and sends it to Bupa, AXA Health or Vitality via Healthcode. Your team then tracks every claim from pending to paid in one dashboard.

Book a demo

Conclusion

Treat M5520 as one line for the whole sphincter episode, whether you implant, remove, or do both. The claim fails when something else rides along with it, like a cystoscopy code, a sling code, or the device cost.

Settle the device route and the pre-authorisation reference before the theatre date, and ask for an operative note that names every component. Do that, and an M5520 claim usually leaves the practice ready to pay. Fix them afterwards, and the same claim comes back for weeks of queries.

Book a demo to see how Pabau carries the pre-authorisation reference from booking to a paid urology claim.

Continue your research

Billing a Bupa patient? Bupa CCSD procedure codes guide covers the Bupa schedule structure, fee lookup, and common urology codes.

Coding endoscopic bladder work instead? CCSD Code M4230 explains the code for endoscopic destruction of a bladder lesion.

Working on the urethra rather than the bladder neck? CCSD Code M7280 walks through billing for urethral valve resection.

Choosing billing software for a UK practice? Best medical billing software in the UK compares the platforms that handle insurer claims and CCSD invoicing.

Frequently asked questions